News

Warren Buffett's Hometown Residents Don't Leave, Even After Becoming Billionaires: 'Get Rich And Then Keep It To Yourself'
Disgraced FTX Founder Sam Bankman-Fried Moved From Brooklyn Jail, Destination Unknown
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Disgraced FTX Founder Sam Bankman-Fried Moved From Brooklyn Jail, Destination Unknown
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Tesla's AI Investments and Upcoming Shareholder Vote Would Determine Future Growth: Morgan Stanley Analyst
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review

Recent News

Are Nvidia Earnings Bullish For Crypto? Trader Highlights The 'Only Crypto With Significant Ties To NVDA'
With Nvidia’s earnings announcement around the corner, the crypto world buzzes with anticipation, particularly around AI and DePIN (Decentralized Physical Infrastructure Networks) projects.
Toll Brothers' Margin Outlook Conservative - Analysts Explain Why
Toll Brothers' conservative margin guidance prompts analysts' concerns despite impressive quarterly performance and order beat.
Toll Brothers Shares Dip On Q2 Results Despite Earnings Beat
Toll Brothers (NYSE:TOL) shares experienced a decline Wednesday afternoon following the release of their second-quarter 2024 financial results, despite reporting earnings that exceeded analyst expectations. 
VanEck's Spot Ethereum ETF Listed On DTCC As SEC Decision Looms
Amid growing anticipation about the potential approval of a spot Ether exchange-traded fund (ETF) in the United States, global investment manager VanEck's ETF has been listed by the Depository Trust and Clearing Corporation (DTCC)
Aon Faces Challenges With Integration Risks And Slow Growth: BofA Downgrades Stock
BofA Securities analyst downgrades Aon plc to Underperform, citing underperformance, integration risk, and management changes. $306 price target.
Arthur Hayes: Bitcoin Could Strengthen As Policymakers Choose 'Easy Button' To Avoid Raising Rates
In his latest blog post, BitMex co-founder Arthur Hayes pointed out how he sees global economic policies influencing the broader economic landscape and the future of cryptocurrencies.
Russia Launches Alleged Space Weapon: What You Need To Know About The US Response
U.S.-Russia tensions rise as Russia launches suspected counterspace weapon against U.S. satellite. U.S. monitoring and assessing the situation.
How Do Li Auto & XPeng Stack Up Post Q1 Earnings?
China-based electric vehicle makers XPeng (NYSE: XPEV) and Li Auto (NASDAQ: LI) recently unveiled first-quarter 2024 results.
Target Q1 Earnings Miss Estimates, Comps Decline Y/Y
Target Corporation (NYSE: TGT) came up with first-quarter fiscal 2024 results, wherein the top line marginally came ahead of the Zacks Consensus Estimate, while the bottom line missed the same. However, both the metrics declined year over year.
Markets Await Existing Home Sales Numbers
Pre-market futures are slightly into the red at this hour. Although we've seen nice gains on all major indices month-to-date — the Dow +5%, S&P 500 +5.3%, the small-cap Russell 2000 +5.7% and the Nasdaq +7% — we look to have flattened off somewhat over the past week.
Why Is Garmin Stock Falling Today?
Garmin stock downgraded to Underperform by B of A analyst due to concerns about growth momentum and valuation. Q1 results beat estimates.
Transcat Analysts Boost Their Forecasts After Upbeat Results
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Norwegian Cruise Line Should Strengthen Cost Management, Says Analyst
BofA Securities analyst Andrew G. Didora reiterated a Neutral rating on Norwegian Cruise Line Holdings with a price target of $20.00. The cruise operator raised its 2024 adjusted earnings guidance to $1.42 per share and introduced new 2026 targets with earnings around $2.45 per share. NCLH aims for net leverage of 4.5x by 2026, assuming $7 billion in operating cash flow.
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the health risks of their blood thinner Plavix. The ruling follows a previous $834 million judgment

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers